v3.26.1
Statement of Cash Flows (Tables)
 3 Months Ended
Mar. 31, 2026
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:
March 31,
(In millions)
2026
2025
Cash and cash equivalents$2,962.6 $3,090.2 
Restricted cash included in Other current assets
8.0 2.8 
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows
$2,970.6 $3,093.0 
Restrictions on Cash and Cash Equivalents
The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:
March 31,
(In millions)
2026
2025
Cash and cash equivalents$2,962.6 $3,090.2 
Restricted cash included in Other current assets
8.0 2.8 
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows
$2,970.6 $3,093.0 
Summary of Non-Cash Investing and Financing Activities
March 31,December 31,March 31,December 31,
(In millions)
2026
2025
2025
2024
Accrued capital expenditures$162.5 $178.8 $105.9 $151.6 
Accrued contingent consideration in connection with acquisitions
$60.7 $58.9 $43.1 $62.7